ST. PAUL, Minn. and VANCOUVER, Wash., Dec. 18, 2023 /PRNewswire/ -- Intending to reshape the landscape of at-home medical diagnostic testing, GRIP Molecular Technologies (GRIP) and Molecular Testing ...
Gastrointestinal (GI) infections present a formidable challenge to healthcare systems. As we navigate this landscape, we recognize that there are numerous benefits when moving from conventional to ...
WICHITA, Kan. (KSNW) — As respiratory illnesses continue to surge across the state of Kansas, Wichita State University’s Molecular Diagnostic Lab has announced they are extending free testing through ...
cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
U.K. and E.U. regulatory submissions NASHVILLE, Tenn., (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) (“iMDx”) today announced that in February the company completed several ...
THE COLONY, Texas (CBSDFW.COM) - There's a lab in North Texas where dedicated employees are working 70 hour weeks to speed up the results of COVID-19 testing. Dallas County and others depend on the ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
Strategic partnership delivers scalable, CLIA-certified capillary blood testing to support rural Medicaid programs and ...
NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.
WICHITA, Kan. (KWCH) - Wichita State’s Molecular Diagnostics Lab (MDL) is open and continues to process thousands of COVID tests with 24-hour results, but the lab has temporarily suspended its COVID ...
Two medical oncologists break down the role molecular testing has when treating NSCLC, from guidelines to common methods to barriers. Joshua Sabari, MD: I recommend testing up front. All patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results